Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Martin J. Driscoll currently holds 47,425 shares of JAVELIN PHARMACEUTICALS, INC (JAV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin J. Driscoll has been a net buyer of JAV stock. They have purchased $955.6K and sold $833 worth of shares.
Martin J. Driscoll's most recent insider trade was on Nov 20, 2020, when they sold 175 shares at $4.76 per share.
Martin J. Driscoll serves as Executive at JAVELIN PHARMACEUTICALS, INC (JAV). They have executed 46 insider transactions totaling $956.4K over their tenure at the company.
Martin J. Driscoll holds the position of Executive at JAVELIN PHARMACEUTICALS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Martin J. Driscoll has shown a buying trading pattern, with $955.6K in total purchases and $833 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Martin J. Driscoll was on Jul 2, 2010, when they sold $395.0K worth of JAV shares. This transaction involved 179,529 shares at $2.20 per share.
Martin J. Driscoll currently owns 47,425 shares of JAVELIN PHARMACEUTICALS, INC (JAV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Martin J. Driscoll's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Martin J. Driscoll has 46 Form 4 filings on record as an insider at JAVELIN PHARMACEUTICALS, INC.
Set alerts for Martin J. Driscoll and 40,000+ other insiders.